RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells

Makoto Suzuki, Noriaki Sunaga, David S. Shames, Shinichi Toyooka, Adi F. Gazdar, John D. Minna

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

DNA methyltransferase 1 (DNMT1) is required to maintain DNA methylation patterns in mammalian cells, and is thought to be the predominant maintenance methyltransferase gene. Recent studies indicate that inhibiting DNMT1 protein expression may be a useful approach for understanding the role of DNA methylation in tumorigenesis. To this end, we used RNA interference to specifically down-regulate DNMT1 protein expression in NCI-H1299 lung cancer and HCC1954 breast cancer cells. RNA interference-mediated knockdown of DNMT1 protein expression resulted in >80% reduction of promoter methylation in RASSF1A, p16ink4A, and CDH1 in NCI-H1299; and RASSF1A, p16 ink4A, and HPP1 in HCC1954; and re-expression of p16 ink4A, CDH1, RASSF1A, and SEMA3B in NCI-H1299; and p16 ink4A, RASSF1A, and HPP1 in HCC1954. By contrast, promoter methylation and lack of gene expression was maintained when these cell lines were treated with control small interfering RNAs. The small interfering RNA treatment was stopped and 17 days later, all of the sequences showed promoter methylation and gene expression was again dramatically down-regulated, indicating the tumor cells still were programmed for these epigenetic changes. We saw no effects on soft agar colony formation of H1299 cells 14 days after DNMT1 knockdown indicating that either these genes are not functioning as tumor suppressors under these conditions, or that more prolonged knockdown or other factors are also required to inhibit the malignant phenotype. These results provide direct evidence that loss of DNMT1 expression abrogates tumor-associated promoter methylation and the resultant silencing of multiple genes implicated in the pathogenesis of human lung and breast cancer.

Original languageEnglish
Pages (from-to)3137-3143
Number of pages7
JournalCancer Research
Volume64
Issue number9
DOIs
Publication statusPublished - May 1 2004
Externally publishedYes

Fingerprint

Methyltransferases
RNA Interference
Lung Neoplasms
Protein Methyltransferases
Breast Neoplasms
Gene Expression
Methylation
DNA
DNA Methylation
Small Interfering RNA
Gene Silencing
Epigenomics
Carcinogens
Genes
Agar
Neoplasms
Carcinogenesis
Down-Regulation
Maintenance
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells. / Suzuki, Makoto; Sunaga, Noriaki; Shames, David S.; Toyooka, Shinichi; Gazdar, Adi F.; Minna, John D.

In: Cancer Research, Vol. 64, No. 9, 01.05.2004, p. 3137-3143.

Research output: Contribution to journalArticle

Suzuki, Makoto ; Sunaga, Noriaki ; Shames, David S. ; Toyooka, Shinichi ; Gazdar, Adi F. ; Minna, John D. / RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells. In: Cancer Research. 2004 ; Vol. 64, No. 9. pp. 3137-3143.
@article{b60ca63f55d44534b74a133f449fc782,
title = "RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells",
abstract = "DNA methyltransferase 1 (DNMT1) is required to maintain DNA methylation patterns in mammalian cells, and is thought to be the predominant maintenance methyltransferase gene. Recent studies indicate that inhibiting DNMT1 protein expression may be a useful approach for understanding the role of DNA methylation in tumorigenesis. To this end, we used RNA interference to specifically down-regulate DNMT1 protein expression in NCI-H1299 lung cancer and HCC1954 breast cancer cells. RNA interference-mediated knockdown of DNMT1 protein expression resulted in >80{\%} reduction of promoter methylation in RASSF1A, p16ink4A, and CDH1 in NCI-H1299; and RASSF1A, p16 ink4A, and HPP1 in HCC1954; and re-expression of p16 ink4A, CDH1, RASSF1A, and SEMA3B in NCI-H1299; and p16 ink4A, RASSF1A, and HPP1 in HCC1954. By contrast, promoter methylation and lack of gene expression was maintained when these cell lines were treated with control small interfering RNAs. The small interfering RNA treatment was stopped and 17 days later, all of the sequences showed promoter methylation and gene expression was again dramatically down-regulated, indicating the tumor cells still were programmed for these epigenetic changes. We saw no effects on soft agar colony formation of H1299 cells 14 days after DNMT1 knockdown indicating that either these genes are not functioning as tumor suppressors under these conditions, or that more prolonged knockdown or other factors are also required to inhibit the malignant phenotype. These results provide direct evidence that loss of DNMT1 expression abrogates tumor-associated promoter methylation and the resultant silencing of multiple genes implicated in the pathogenesis of human lung and breast cancer.",
author = "Makoto Suzuki and Noriaki Sunaga and Shames, {David S.} and Shinichi Toyooka and Gazdar, {Adi F.} and Minna, {John D.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1158/0008-5472.CAN-03-3046",
language = "English",
volume = "64",
pages = "3137--3143",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells

AU - Suzuki, Makoto

AU - Sunaga, Noriaki

AU - Shames, David S.

AU - Toyooka, Shinichi

AU - Gazdar, Adi F.

AU - Minna, John D.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - DNA methyltransferase 1 (DNMT1) is required to maintain DNA methylation patterns in mammalian cells, and is thought to be the predominant maintenance methyltransferase gene. Recent studies indicate that inhibiting DNMT1 protein expression may be a useful approach for understanding the role of DNA methylation in tumorigenesis. To this end, we used RNA interference to specifically down-regulate DNMT1 protein expression in NCI-H1299 lung cancer and HCC1954 breast cancer cells. RNA interference-mediated knockdown of DNMT1 protein expression resulted in >80% reduction of promoter methylation in RASSF1A, p16ink4A, and CDH1 in NCI-H1299; and RASSF1A, p16 ink4A, and HPP1 in HCC1954; and re-expression of p16 ink4A, CDH1, RASSF1A, and SEMA3B in NCI-H1299; and p16 ink4A, RASSF1A, and HPP1 in HCC1954. By contrast, promoter methylation and lack of gene expression was maintained when these cell lines were treated with control small interfering RNAs. The small interfering RNA treatment was stopped and 17 days later, all of the sequences showed promoter methylation and gene expression was again dramatically down-regulated, indicating the tumor cells still were programmed for these epigenetic changes. We saw no effects on soft agar colony formation of H1299 cells 14 days after DNMT1 knockdown indicating that either these genes are not functioning as tumor suppressors under these conditions, or that more prolonged knockdown or other factors are also required to inhibit the malignant phenotype. These results provide direct evidence that loss of DNMT1 expression abrogates tumor-associated promoter methylation and the resultant silencing of multiple genes implicated in the pathogenesis of human lung and breast cancer.

AB - DNA methyltransferase 1 (DNMT1) is required to maintain DNA methylation patterns in mammalian cells, and is thought to be the predominant maintenance methyltransferase gene. Recent studies indicate that inhibiting DNMT1 protein expression may be a useful approach for understanding the role of DNA methylation in tumorigenesis. To this end, we used RNA interference to specifically down-regulate DNMT1 protein expression in NCI-H1299 lung cancer and HCC1954 breast cancer cells. RNA interference-mediated knockdown of DNMT1 protein expression resulted in >80% reduction of promoter methylation in RASSF1A, p16ink4A, and CDH1 in NCI-H1299; and RASSF1A, p16 ink4A, and HPP1 in HCC1954; and re-expression of p16 ink4A, CDH1, RASSF1A, and SEMA3B in NCI-H1299; and p16 ink4A, RASSF1A, and HPP1 in HCC1954. By contrast, promoter methylation and lack of gene expression was maintained when these cell lines were treated with control small interfering RNAs. The small interfering RNA treatment was stopped and 17 days later, all of the sequences showed promoter methylation and gene expression was again dramatically down-regulated, indicating the tumor cells still were programmed for these epigenetic changes. We saw no effects on soft agar colony formation of H1299 cells 14 days after DNMT1 knockdown indicating that either these genes are not functioning as tumor suppressors under these conditions, or that more prolonged knockdown or other factors are also required to inhibit the malignant phenotype. These results provide direct evidence that loss of DNMT1 expression abrogates tumor-associated promoter methylation and the resultant silencing of multiple genes implicated in the pathogenesis of human lung and breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=2342575723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342575723&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-03-3046

DO - 10.1158/0008-5472.CAN-03-3046

M3 - Article

C2 - 15126351

AN - SCOPUS:2342575723

VL - 64

SP - 3137

EP - 3143

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 9

ER -